Pfizer expects $59.5B-$62.5B 2026 revenue, cites post-2028 high single-digit CAGR visibility after Vyndamax settlement

Seeking Alpha — May 05, 18:03 PM

Read full article at Seeking Alpha →

Pfizer beats Q1 earnings estimates

• Pfizer's newer drugs pushed earnings past Wall Street expectations Quartz — May 05, 12:50 PM
• Pfizer Posts Better-Than-Expected Revenue, Profit Wall Street Journal — May 05, 12:35 PM
• Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending Wall Street Journal — May 05, 11:23 AM
• Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth CNBC — May 05, 10:55 AM
• Earnings Snapshot: Pfizer beats Q1 estimates but misses guidance Seeking Alpha — May 05, 10:59 AM